Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
58.9M
-
Number of holders
-
150
-
Total 13F shares, excl. options
-
43.9M
-
Shares change
-
+98.3K
-
Total reported value, excl. options
-
$206M
-
Value change
-
-$265K
-
Put/Call ratio
-
0.21
-
Number of buys
-
68
-
Number of sells
-
-73
-
Price
-
$4.69
Significant Holders of Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share (VNDA) as of Q3 2024
181 filings reported holding VNDA - Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share as of Q3 2024.
Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share (VNDA) has 150 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 43.9M shares
of 58.9M outstanding shares and own 74.51% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (8.6M shares), RENAISSANCE TECHNOLOGIES LLC (4.01M shares), VANGUARD GROUP INC (3.63M shares), TANG CAPITAL MANAGEMENT LLC (2.35M shares), DIMENSIONAL FUND ADVISORS LP (2.26M shares), ACADIAN ASSET MANAGEMENT LLC (1.9M shares), Nantahala Capital Management, LLC (1.59M shares), JACOBS LEVY EQUITY MANAGEMENT, INC (1.43M shares), GEODE CAPITAL MANAGEMENT, LLC (1.43M shares), and STATE STREET CORP (1.17M shares).
This table shows the top 150 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.